SYNOPSIS
The reciprocals of the blood urea nitrogen and plasma creatinine levels, the maximum specific gravity of the urine after vasopressin, and three modified forms of the phenolsulphonphthalein (P.S.P.) excretion test were found to be directly related to the glomerular filtration rate (G.F.R.) in hospital patients. From 34 to 75 patients were studied for each test, and in 21 patients all tests were performed concurrently.
The plasma creatinine level and the 15-minute urinary excretion of P.S.P. were found to be the most useful simple tests of renal function and gave sufficiently accurate estimates of total function (G.F.R.) to (females). plasma creat(nlne plasma creatinine In the presence of impaired renal function more accurate estimates of G.F.R. were obtained from the plasma creatinine and P.S.P. excretion tests (S.D. ofestimate 8 and 13 ml./min. respectively). It was thought that these tests could well replace the commonly used blood urea nitrogen estimation as simple tests of renal function.
It has generally been regarded that renal function consists of two relatively distinct aspects, glomerular filtration and tubular activity, for each of which tests of varying degrees of complexity have been devised. However, there is a growing recognition that in the majority of renal diseases both aspects suffer more or less equally and that a measure of glomerular filtration rate (G.F.R.) alone provides a reasonable assessment of the total renal functional mass. The most accurate methods for measuring G.F.R. are the inulin clearance and the endogenous creatinine clearance, which are equally reliable provided errors due to false chromogens in the creatinine estimation are eliminated (Haugen and Blegen, 1953; Edwards, 1959a) . Creatinine clearance can be measured with less trouble than the inulin Received for publication 16 December 1963. clearance, and has proved valuable in assessing the progress of renal failure (Edwards, 1959b; Edwards and Whyte, 1959a; Wrong, 1962) . Even so, it is a relatively complex and inconvenient procedure, and there is a need for simpler methods for measuring renal function in clinical practice. In this regard, the plasma creatinine level, the blood urea nitrogen level, the urea clearance, and the maximum urinary specific gravity achieved after water deprivation have been examined previously (Edwards and Whyte, 1959b; Castaldi, Edwards, and Whyte, 1960) using the G.F.R. estimated from creatinine clearance as a yardstick of renal function. It was concluded that the plasma creatinine level was a more sensitive indicator of renal function than the blood urea level if males and females were treated separately and muscle wasting was not present, and that G.F.R. 557 could be predicted reasonably well from the specific gravity test in generalized renal disease. Doolan, Alpen, and Theil (1962) came to similar conclusions with regard to plasma creatinine and creatinine chromogen levels as tests of renal function in naval personnel, but advised the measurement of full creatinine clearance wherever possible.
The present report confirms and extends the previous work and gives an assessment of four additional tests, namely, the maximum urinary specific gravity produced after an injection of vasopressin, the plasma level of phenolsulphonphthalein (phenol red, P.S.P.) 30 minutes after its intravenous injection, and the urinary excretion of this dye in 15 minutes and two hours. The most satisfactory of these tests proved to be the 15-minute excretion of phenolsulphonphthalein. The G.F.R. could be predicted with reasonable accuracy from the results of the test and, being simple and rapid, it seems that the test deserves greater recognition. Rowntree and Geraghty (1910) were the first to suggest the use of P.S.P. for testing renal function. They recommended an intramuscular injection of 1 ml. (6 mg.) for all patients, regardless of body weight or size, and found that 40 (Edwards and Whyte, 1960) , and have made a critical assessment of its relation to the glomerular filtration rate.
MATERIAL AND METHODS
The 75 patients were admitted to the Medical Research Ward, Sydney Hospital, for treatment of anuria or for investigation of renal function. Thirteen were in the diuretic phase of 'acute tubular necrosis' (five with superadded renal infection); 11 were recovering from decompensation of chronic renal failure due to chronic pyelonephritis; six were recovering from acute glomerulonephritis; 15 had compensated chronic renal failure associated with hypertensive cardiovascular disease (5), chronic pyelonephritis (5), chronic glomerulonephritis (4), and polycystic disease (1); 14 had essential hypertension without renal failure; 14 were 'normals' (hospital patients without evidence of cardiovascular, renal, or electrolyte disorders); and only two had renal medullary syndromes without impaired glomerular function (renal tubular acidosis, medullary nephrocalcinosis); there were no cases of acute pyelonephritis, and none with recurrent pyelonephritis in the absence of chronic renal failure.
CREATININE CLEARANCE AND PLASMA CREATININE LEVEL The methods have been described fully elsewhere Whyte, 1958, 1959b) . The patient was given no tea, coffee, meat, fish, or drugs in the 12 hours preceding the test. Over a preliminary period of two hours 750 ml. of water was given and then 200 ml. was given each hour for six hours during which two accurately timed three-hour collections of urine were made. A heparinized blood sample was collected at some time during the test.
Creatinine was measured in plasma and urine by separating it from other chromogens by adsorption on to fuller's earth, with subsequent elution of creatinine and the development of colour with alkaline picrate. Protein precipitation, pH, and temperature were controlled. The endogenous creatinine clearance was corrected to a surface area of 1-73 square metres.
UREA NITROGEN Urea nitrogen in blood and urine was measured in the Biochemistry Department by an automated diacetyl tec'nique (AutoAnalyzer method 2).
THE VASOPRESSIN TEST Without special preparation of the patient, 1 ml. (5 units) of vasopressin tannate in oil (Pitressin) was administered intramuscularly at 7 a.m. The ampoule was warmed and shaken to ensure that the hormone was dissolved. The specific gravity of the urine passed at 10 a.m., 1 p.m., and 4 p.m. was measured and corrected for temperature and gross proteinuria. Glycosuria was not encountered. The maximum specific gravity attained was recorded (de Wardener, 1956 ). P.S.P. TESTS These measured the level of the dye in plasma and the concentration of P.S.P. in urine.
(a) Plasma level Previous studies (Healy, 1959, unpublished observations) showed that the plasma concentrations of the dye fell rapidly after an intravenous injection in 13 patients with normal renal function and more slowly in 30 patients with varying degrees of renal impairment. The discrepancies were well established by 30 minutes and, with the dosage employed, plasma levels, were still high enough at this time to be accurately measured. Therefore the plasma level at 30 minutes was selected for examination as an index of renal function in a larger series of patients.
The patients were fasted overnight and kept recumbent throughout the test. A water load of 500 ml. was given in the half-hour preceding the injection. After withdrawing 10 ml. of blood for a plasma blank a dose of 3 ml. (18 mg.) of P.S.P. per square metre of body surface area was injected through the same needle. Blood was drawn into the syringe and mixed with the dye and the injection completed in one minute. At 30 minutes a second sample of heparinized blood was collected. A modification of the method of Ochwadt and Pitts (1956) was used for estimating the plasma level of phenolsulphonphthalein. Four ml. of plasma from each sample was pipetted into large, glass-stoppered contrifuge tubes with 10 ml. of acetone, 2 ml. of concentrated detergent (Teepol), and 3 drops of 50% sodium hydroxide. The tubes were then vigorously shaken. Plasma proteins and any free haemoglobin were precipitated by the acetone and residual turbidity was removed by the detergent. The tubes were then centrifuged at 3,000 r.p.m. for five minutes. The clear supernatant, coloured pink in the specimen containing the P.S.P., was poured into cells with a 4 cm. light path, covered, and the optical density measured in a Unicam spectrophotometer at a wavelength of 560 m,u. The concentration of P.S.P. in milligrams per 100 ml. was determined by reference to a previously prepared calibration curve for known concentrations of P.S.P. added to pooled human plasma.
(b) The urine tests The same ward procedure was used as in (a) but when the plasma level of dye was not being measured fasting was not necessary. The bladder was emptied and all urine collected at exactly 15 minutes and again at two hours after the injection of dye. The concentration of P.S.P. in the urine was measured by pipetting 1 volume of urine and 1 volume of 50 % sodium hydroxide into a volumetric flask and making it up to 20 volumes with water. Occasionally the solution was not water clear, in which case it was centrifuged at 3,000 r.p.m. for five minutes. The optical density of the reddishpurple solution was then read in a 1 cm. cell in a Unicam spectrophotometer at a wavelength of 560 m,u. The reading was converted to P.S.P. concentration by reference to a previously prepared calibration curve. The total volumes of the 15-minute and two-hour urine collections were measured and the quantities of P.S.P. in each expressed as a percentage of the injected dose. The calibration curves for both the urine and plasma P.S.P. standards were linear.
Results were analysed statistically according to Moroney (1956) and Quenouille (1952 G.F.R. estimated from 15-minute P.S.P. excretion = 4-6 x P.S.P. % (males) or 3-7 x P.S.P. % (females), with S.D. ± 24 ml./min. 'Data taken from previous publications (Edwards and Whyte, 1959b; Castaldi et al., 1960) . Table   II ). The tests examined in this study proved to be superior to the blood urea nitrogen level. exertion before the test. In the past, inaccurate methodology has limited the usefulness of the test (Milne, 1957) , but techniques are now available with a 'standard error of the method' of 1-6% (Edwards and Whyte, 1958) . With the advent of auto-analyzers, more extensive use of this test is becoming feasible (Chasson, Grady, and Stanley, 1961) . Routine reporting of the estimated G.F.R., calculated separately for males and females, facilitates the interpretation of results. For this purpose, the simplified relationships of G. shown in Table II , are satisfactory. It is important to observe sex differences and reciprocal relationships in these equations, as stressed previously (Edwards and Whyte, 1959b) , otherwise the test appears less useful (Wrong, 1962 The modified 15-minute urinary P.S.P. test can be performed very rapidly in a modestly equipped laboratory. It is possible that it could be carried out satisfactorily but with some loss of precision with a simple colour comparator of the type advocated for haemoglobin estimations. In that case the test could readily be performed in the ward, the clinic, or in the doctor's surgery. The dye is cheap and although a small number of patients suffer allergic reactions, no serious toxicity has been ascribed to it in spite of long and extensive use. The test has the disadvantage of requiring complete emptying of the bladder at one specified time, but there is no necessity for the bladder to be emptied at the time of the injection. Incomplete emptying will lead to falsely low estimates of renal function, as with clearance procedures, and it is wise to ensure a good urinary flow.
The results indicate that the accuracy of the test as a means of predicting G.F.R. is increased where the G.F.R. is reduced and therefore it is of considerable value in following progress in known renal disease.
Phenolsulphonphthalein is actively secreted by the proximal tubules (Marshall and Vickers, 1923; Chambers and Kempton, 1933; Forster, 1948; Taggart and Forster, 1950; Young and Edwards, 1963) aided by an enzyme complex which is also involved in the transport of other substances (Beyer, Painter, and Wiebelhaus, 1950; Smith, 1951; Taggart, 1958; Edwards, Crawford, Dempster, Milne, and Sicinski, 1961; Edwards, 1962) . As there is a maximal tubular excretory rate for P.S.P. which is exceeded when the plasma level rises much above 1 mg. per 100 ml. (Marshall and Crane, 1924; Shannon, 1935; Smith, Goldring, and Chasis, 1938) , the dose of P.S.P. used in this work was selected to avoid exceeding this critical plasma concentration. It was felt that a dose given according to body surface area would allow for individual differences in plasma volume (Edwards and Whyte, 1960) (Taggart, 1958; Edwards, 1962) and for this reason these were not given in the 24 hours preceding the P.S.P.
tests. Gouty subjects were also avoided in case tubular reabsorption of uric acid should compete with P.S.P. excretion. Also, Rowntree and Geraghty (1910) and Marshall and Vickers (1923) demonstrated some hepatic uptake and excretion of P.S.P.
by mechanisms thought to be similar to those found in the renal tubules (Edwards, 1961) , and for this reason patients with severe liver disease were not included in the present study. Again, since 75 % of the dye is bound to albumin in the plasma (Marshall and Vickers, 1923; Grollman, 1925) (Wrong, 1962) or angina in patients with coronary artery disease (Goodman and Gilman, 1955 (Wrong and Davies, 1959; Edwards, 1962) . It is an interesting feature of all these tests that although they individually test different parts of the nephron, the majority seem to bear a linear relationship to the G.F.R. and therefore to each other. This supports the increasingly popular theory that most renal diseases affect, and cause the loss of, whole nephrons rather than particular aspects of nephron function. Thus urinary concentrating ability, the excretion of creatinine, urea, and P.S.P., and even ammonia synthesis by the collecting ducts seem to show a linear relationship to G.F.R. in generalized renal disease (Wrong, 1962; Edwards, 1962) .
